NCT03673722

Brief Summary

In cohort studies, a Mediterranean Dietary Pattern (MDP) has been consistently associated with reduced dementia incidence. The efficacy of a MDP to prevent dementia has never been directly demonstrated by RCTs, with existing research limited to cognition as a secondary outcome. Furthermore, despite their likely additive effects, the combined impact of Physical Activity (PA) and a MDP on dementia risk is unknown. MedEx-UK is a RCT that will evaluate the feasibility of a multi-domain intervention to increase Mediterranean Dietary Pattern (MDP) adherence and physical activity (PA) in a group of older UK adults who are at above average risk of dementia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2021

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2023

Completed
Last Updated

December 21, 2023

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

August 17, 2018

Last Update Submit

December 20, 2023

Conditions

Keywords

Mediterranean DietPhysical ActivityDementiaAlzheimer DiseaseCognition

Outcome Measures

Primary Outcomes (2)

  • Increase in MDP using the 14-point MEDAS scale

    The extent to which the Mediterranean Dietary Pattern has improved, the target being an increase in 3 points of a 14-point scale, as assessed by Dietary Recall software (Intake 24) and a validated questionnaire (14-point MEDAS)

    24 weeks

  • Increase in PA using activity monitors

    The extent to which Physical Activity levels have increased, the target being 150 minutes of moderate activity per week, assessed using an activity monitor worn by participants throughout the 24 week intervention period

    24 weeks

Secondary Outcomes (7)

  • Cognition

    24 weeks

  • Neuroimaging

    24 weeks

  • Vascular function

    24 weeks

  • QRISK3 score

    24 weeks

  • Blood pressure

    24 weeks

  • +2 more secondary outcomes

Study Arms (3)

MDP only

EXPERIMENTAL

Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern through interaction with the online LEAP2 platform

Other: Foods consistent with a MDP

MDP plus PA

EXPERIMENTAL

Participants will be asked to increase their consumption of foods that are consistent with a Mediterranean Dietary Pattern AND to increase Physical Activity using a mixture of structured and non-structured activities through interaction with the online LEAP2 platform

Other: Foods consistent with a MDPOther: Physical Activity

Control

PLACEBO COMPARATOR

Participants will be given generic healthy eating advice based on the NHS 'Eatwell' plate and British Heart Foundation (BHF) guidelines

Other: Control

Interventions

We aim to increase MDP by 3 points, according to a 14-point MEDAS score

MDP onlyMDP plus PA

We aim to increase PA to 150 minutes moderate activity per week.

MDP plus PA
ControlOTHER

Participants will be given generic healthy eating advice based

Control

Eligibility Criteria

Age55 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female, aged 55-74 years
  • Understands and is willing and able to comply with all study procedures, including changes to diet and physical activity levels
  • Access to, and able to use, the internet/computer/tablet device
  • QRISK3 score of \>=15 (assessed by GP)
  • Subjective Memory Complaints (SMC), based on a score of \>16 on the Cognitive Change Index (CCI) (from the first 12 items)
  • Stable use of any prescribed medication for at least four weeks
  • Normal (or corrected to normal) vision and hearing
  • Fluent in written and spoken English
  • Willing and able to provide written informed consent

You may not qualify if:

  • Diagnosis of Alzheimer's disease (AD), other form of dementia, Mild Cognitive Impairment (MCI), or significant neurological disorder
  • Cognition not within normal range, based on a score of \<26 on the Montreal Cognitive Assessment (MoCA); or an indication of cognitive decline, based on a score of ≥2 on Ascertain Dementia (AD-8)
  • Evidence of impairment of Instrumental Activities of Daily living (IADLS)
  • Current psychotic illness (delusional disorder/schizophrenia)
  • History of serious mental illness know to affect cognition (schizophrenia, schizoaffective disorder, bipolar disorder)
  • Subjects with other clinically diagnosed psychiatric disorders likely to affect the cognitive measures (as judged by a clinical advisor)
  • HIV positive
  • Past history or previous MRI evidence of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery, stroke, or serious neurological disorders
  • History of alcohol or drug dependency in the last 2 years
  • Subjects with existing diagnosed gastrointestinal disorders likely to impact study results (as judged by a clinical advisor)
  • History of any major cardiovascular event, such as a myocardial infarction, stroke or TIA
  • Diagnosed COPD
  • Cancer, or cancer/treatment within the last 12 months
  • Diagnosis of type 1 or type 2 diabetes \< 3 months ago
  • Clinical diagnosis of liver or kidney disease
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Birmingham

Birmingham, B15 2TT, United Kingdom

Location

Newcastle University

Newcastle upon Tyne, NE2 4HH, United Kingdom

Location

University of East Anglia

Norwich, NR4 7UQ, United Kingdom

Location

Related Publications (3)

  • Jennings A, Shannon OM, Gillings R, Lee V, Elsworthy R, Bundy R, Rao G, Hanson S, Hardeman W, Paddick SM, Siervo M, Aldred S, Mathers JC, Hornberger M, Minihane AM. Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial. BMC Med. 2024 Dec 23;22(1):600. doi: 10.1186/s12916-024-03815-z.

  • Elsworthy RJ, Jong ST, Hanson S, Shannon OM, Jennings A, Gillings R, Siervo M, Hornberger M, Hardeman W, Mathers JC, Minihane AM, Aldred S. Effects of the COVID-19 associated United Kingdom lockdown on physical activity in older adults at high risk of cardiovascular disease: a mixed methods perspective from the MedEx-UK multicenter trial. Front Public Health. 2024 May 9;12:1371453. doi: 10.3389/fpubh.2024.1371453. eCollection 2024.

  • Shannon OM, Lee V, Bundy R, Gillings R, Jennings A, Stephan B, Hornberger M, Balanos G, Paddick SM, Hanson S, Hardeman W, Holmes R, Garner N, Aldred S, Siervo M, Mathers JC, Minihane AM. Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial. BMJ Open. 2021 Feb 5;11(2):e042823. doi: 10.1136/bmjopen-2020-042823.

MeSH Terms

Conditions

DementiaMotor ActivityAlzheimer Disease

Interventions

Exercise

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersBehaviorTauopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Anne Marie Minihane, PhD

    University of East Anglia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: RCT
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2018

First Posted

September 17, 2018

Study Start

April 1, 2019

Primary Completion

February 26, 2021

Study Completion

September 7, 2023

Last Updated

December 21, 2023

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations